Regular aerobic exercise, or cardio, may significantly reduce risk of flu or pneumonia death, study finds

Written By :  Dr. Kamal Kant Kohli
Published On 2023-05-17 05:00 GMT   |   Update On 2023-05-17 07:42 GMT

USA: A US research has linked regular aerobic exercise (known as "cardio"), even at weekly levels below recommended, to a significantly lower risk of death from pneumonia or flu. But the findings, published in the British Journal of Sports Medicine, suggest that there may be a level above which the effects plateau or, in the case of muscle strengthening activities-become,...

Login or Register to read the full article

USA: A US research has linked regular aerobic exercise (known as "cardio"), even at weekly levels below recommended, to a significantly lower risk of death from pneumonia or flu. 

But the findings, published in the British Journal of Sports Medicine, suggest that there may be a level above which the effects plateau or, in the case of muscle strengthening activities-become, potentially harmful.

Adults are advised to clock up at least 150 minutes/week of moderate-intensity or 75 minutes of vigorous-intensity, aerobic physical activity, or an equivalent combination, plus muscle-strengthening activity of moderate or greater intensity at least twice a week.

Aerobic exercise, which includes brisk/speed walking, swimming, running, and stair climbing, is sustained, increasing heart rate and working up a sweat. Muscle strengthening activities include using weights and resistance bands; exercises such as squats, lunges, and press-ups (callisthenics); and heavy gardening.

As well as helping to maintain good health and ward off serious illness, regular physical activity may also protect against death from flu or pneumonia, the evidence indicates.

The researchers, therefore, wanted to find out if specific types and amounts of physical activity might be associated with this reduced risk.

They drew on the responses of 577,909 adults who participated in the US nationally representative National Health Interview Survey (NHIS) between 1998 and 2018.

Respondents were asked how often they spent ten or more minutes in vigorous-intensity and light or moderate-intensity aerobic activities. And they were asked how often they did muscle-strengthening activities.

Each person was then categorised according to how well they met recommended aerobic activity + muscle strengthening weekly targets: not meeting either; meeting the aerobic activity target, meeting the muscle-strengthening target, and meeting both targets.

Five levels of physical activity were defined: below 10, 10-149, 150-300, 301-600 and more than 600 mins/week of moderate to vigorous physical activity; and less than 2, 2, 3, 4-6 and 7 or more sessions/week of muscle-strengthening activities.

Half the respondents (50.5%) didn’t meet either weekly target. How well they did so differed significantly according to sociodemographic and lifestyle factors, underlying health conditions, and whether they had been vaccinated against flu and/or pneumonia.

A third (34%) were aerobically inactive, and more than three quarters (78%) reported fewer than 2 weekly muscle-strengthening sessions.

During an average monitoring period of 9 years, 81,431 participants died; 1516 of these deaths were attributed to flu and pneumonia.

Those who met both recommended weekly physical activity targets had nearly half (48%) the risk of dying from flu or pneumonia as their peers who met neither, after accounting for potentially influential factors.

Meeting only the aerobic activity target was associated with a 36% lower risk, after accounting for potentially influential factors, while meeting only the muscle strengthening target wasn’t associated with any significant difference in risk.

In terms of quantity, clocking up 10–149, 150–300, and 301–600 mins/week of aerobic physical activity was associated with, respectively, 21%, 41%, and 50% lower risks, compared with none. But no additional benefit was seen above 600 weekly minutes.

“Although [10-150 mins/week] is often labelled ‘insufficient’ because it falls below the recommended duration, it may confer health benefits relative to physical inactivity,” suggest the researchers.

Regarding muscle-strengthening activities, compared with fewer than two weekly sessions, meeting the weekly target of 2 was associated with a 47% lower risk, but 7 or more sessions were associated with a 41% higher risk.

“While beyond the scope of this study, plausible explanations [for this dichotomy] range from inaccurate responses (such as reporting occupational physical activity, which may not confer the same protective effect as leisure-time physical activity) to haemodynamic ramifications of frequent, high-intensity [muscle strengthening activity],” explain the researchers.

This is an observational study, and as such, can’t establish cause, added to which the researchers acknowledge various limitations. For example, the study relied on personal recall. At one point, the NHIS survey captured only leisure time physical activity in bouts of 10 or more minutes, nor did it distinguish between light and moderate intensity activities.

Nevertheless, the researchers conclude: “Efforts to reduce influenza and pneumonia mortality among adults might focus on decreasing the prevalence of aerobic inactivity and increasing the prevalence of achieving 2 episodes/week of muscle-strengthening activity.”

Reference:

Webber BJ, Yun HC, Whitfield GPLeisure-time physical activity and mortality from influenza and pneumonia: a cohort study of 577 909 US adultsBritish Journal of Sports Medicine Published Online First: 16 May 2023. doi: 10.1136/bjsports-2022-106644.

Tags:    
Article Source : British Journal of Sports Medicine

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News